HighMark Wealth Management’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6 Hold
1
﹤0.01% 563
2026
Q1
$7 Hold
1
﹤0.01% 554
2025
Q4
$4 Hold
1
﹤0.01% 585
2025
Q3
$4 Hold
1
﹤0.01% 607
2025
Q2
$4 Hold
1
﹤0.01% 615
2025
Q1
$6 Hold
1
﹤0.01% 573
2024
Q4
$6 Hold
1
﹤0.01% 574
2024
Q3
$5 Sell
1
-4
-80% -$37 ﹤0.01% 595
2024
Q2
$48 Hold
5
﹤0.01% 578
2024
Q1
$55 Hold
5
﹤0.01% 559
2023
Q4
$50 Hold
5
﹤0.01% 571
2023
Q3
$63 Buy
+5
New +$73 ﹤0.01% 561
2022
Q1
Sell
-4,773
Closed -$40K 532
2021
Q4
$40K Buy
4,773
+12
+0.3% +$103 0.03% 132
2021
Q3
$43K Buy
+4,761
New +$38.5K 0.03% 126

Other funds holding PTEN

HighMark Wealth Management's PTEN Position: Q2 2026 in Review

HighMark Wealth Management held its Patterson-UTI (PTEN) position steady in Q2 2026 at 1 share worth $6. The position accounts for ﹤0.01% of the portfolio, ranked #563.

HighMark Wealth Management first reported a position in PTEN in Q3 2021 and has held it in 14 quarters since. The position peaked at $43K in Q3 2021. 438 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • HighMark Wealth Management held 1 share of Patterson-UTI worth $6 as of Q2 2026.
  • HighMark Wealth Management left its Patterson-UTI share count unchanged in Q2 2026.
  • Patterson-UTI made up ﹤0.01% of HighMark Wealth Management's portfolio in Q2 2026, its #563 holding.
  • HighMark Wealth Management first reported a position in Patterson-UTI in Q3 2021 and has held it in 14 quarters since.
  • HighMark Wealth Management's Patterson-UTI position peaked at $43K in Q3 2021.
  • 438 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on HighMark Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.